Nonspecific antiviral immunity by formalin-fixed Coxiella burnetii is enhanced in the absence of nitric oxide

Virology

Volumn 326, Issue 1, 2004, Pages 1-5

  Rolph, Michael S ^a   Mahalingam, Surendran ^b   Cowden, William B ^a  

^a Biology and Environment   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Antiviral; Coxiella burnetii; IFN ; Nitric oxide; Vaccinia virus

Indexed keywords

FORMALDEHYDE; GAMMA INTERFERON; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; COXIELLA BURNETII; IMMUNITY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINIA; VACCINIA VIRUS; VIRUS REPLICATION; WILD TYPE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; COXIELLA BURNETII; DISEASE MODELS, ANIMAL; FEMALE; FORMALDEHYDE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTORS, INTERFERON; TRYPTOPHAN OXYGENASE; VACCINATION; VACCINIA; VACCINIA VIRUS; VIRUS REPLICATION;

COXIELLA BURNETII; VACCINIA VIRUS;

EID: 3242689964     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.04.049     Document Type: Article

References (30)

1. Adams O., Besken K., Oberdorfer C., MacKenzie C.R., Takikawa O., Daubener W. Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. J. Virol. 78(5):2004;2632-2636
2. Aitken I.D., Bogel K., Cracea E., Edlinger E., Houwers D., Krauss H., Rady M., Rehacek J., Schiefer H.G., Schmeer N., et al. Q fever in Europe: current aspects of aetiology, epidemiology, human infection, diagnosis and therapy. Infection. 15(5):1987;323-327
3. Akarid K., Sinet M., Desforges B., Gougerot-Pocidalo M.A. Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J. Virol. 69:1995;7001-7005
4. Bartholdy C., Nansen A., Christensen J.E., Marker O., Thomsen A.R. Inducible nitric-oxide synthase plays a minimal role in lymphocytic choriomeningitis virus-induced, T cell-mediated protective immunity and immunopathology. J. Gen. Virol. 80(Pt. 11):1999;2997-3005
5. Bi Z., Reiss C.S. Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69:1995;2208-2213
6. Bodaghi B., Goureau O., Zipeto D., Laurent L., Virelizier J.L., Michelson S. Role of IFN-gamma-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J. Immunol. 162(2):1999;957-964
7. Chan J., Xing Y., Magliozzo R.S., Bloom B.R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1992;1111-1122
8. Clark I.A. Resistance to Babesia spp. and Plasmodium sp. in mice pretreated with an extract of Coxiella burnetii. Infect. Immun. 24(2):1979;319-325
9. Cochrane R., Clark R.B., Huang C.K., Cone R.E. Differential regulation of T cell receptor-mediated Th1 cell IFN-gamma production and proliferation by divergent cAMP-mediated redox pathways. J. Interferon Cytokine Res. 21(10):2001;797-807
10. Croen K.D. Evidence for an antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91:1993;2446-2452
11. Florquin S., Amraoui Z., Dubois C., Decuyper J., Goldman M. The protective role of endogenously synthesized nitric oxide in Staphylococcal enterotoxin B-induced shock in mice. J. Exp. Med. 180:1994;1153-1158
12. Howe D., Barrows L.F., Lindstrom N.M., Heinzen R.A. Nitric oxide inhibits Coxiella burnetii replication and parasitophorous vacuole maturation. Infect. Immun. 70(9):2002;5140-5147
13. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R.M., Aguet M. Immune response in mice that lack the interferon-γ receptor. Science. 259:1993;1742-1745
14. Karupiah G., Xie Q.W., Buller R.M.L., Nathan C., Duarte C., MacMicking J.D. Inhibition of viral replication by interferon-gamma induced nitric oxide synthase. Science. 261(5127):1993;1445-1448
15. Kelly M.T. Activation of guinea pig macrophages by Q fever rickettsiae. Cell. Immunol. 28:1977;198-205
16. Kovacova E., Kazar J. Q fever - Still a query and underestimated infectious disease. Acta Virol. 46(4):2002;193-210
17. Liew F.Y., Millott S., Parkinson C., Palmer R.M.J., Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:1990;4794-4797
18. MacMicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., Stevens K., Xie Q., Sokol K., Hutchinson N., Chen H., Mudgett J.S. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:1995;641-650
19. Mahalingam S., Farber J.M., Karupiah G. The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo. J. Virol. 73(2):1999;1479-1491
20. Muñoz-Fernández M.A., Fernández M.A., Fresno M. Synergism between tumor necrosis factor-α and interferon-γ on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur. J. Immunol. 22:1992;301-307
21. Rockett K.A., Awburn M.M., Aggarwal B.B., Cowden W.B., Clark I.A. In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1 - Possible roles in malaria. Infect. Immun. 60(9):1992;3725-3730
22. Rolph M.S., Cowden W.B., Medvecsky C.J., Ramshaw I.A. A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo. J. Virol. 70:1996;7678-7685
23. Rolph M.S., Ramshaw I.A., Rockett K.A., Ruby J., Cowden W.B. Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance. Virology. 217:1996;470-477
24. Shtrichman R., Samuel C.E. The role of gamma interferon in antimicrobial immunity. Curr. Opin. Microbiol. 4(3):2001;251-259
25. Van der Meide P.H., de Labie M.C., Botman C.A., Aten J., Weening J.J. Nitric oxide suppresses IFN-gamma production in the spleen of mercuric chloride-exposed brown Norway rats. Cell. Immunol. 161:1995;195-206
26. Waag D.M., Kende M., Damrow T.A., Wood O.L., Williams J.C. Injection of inactivated phase I Coxiella burnetii increases non-specific resistance to infection and stimulates lymphokine production in mice. Ann. N. Y. Acad. Sci. 590:1990;203-214
27. Zamboni D.S., Rabinovitch M. Nitric oxide partially controls Coxiella burnetii phase II infection in mouse primary macrophages. Infect. Immun. 71(3):2003;1225-1233
28. Zaragoza C., Ocampo C., Saura M., Leppo M., Wei X.Q., Quick R., Moncada S., Liew F.Y., Lowenstein C.J. The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. Proc. Natl. Acad. Sci. U.S.A. 95(5):1998;2469-2474
29. Zvilich M., Williams J.C., Waag D., Rill W.R., Bell P., Kende M. Efficacy of Coxiella burnetii and its chloroform-methanol residue (CMR) fraction against Rift Valley fever virus infection in mice. Antiviral. Res. 27(1-2):1995;137-149
30. Zvilich M., Williams J.C., Waag D., Rill W.R., Malli R.J., Bell P., Kende M. Characterization of the non-specific humoral and cellular antiviral immunity stimulated by the chloroform-methanol residue (CMR) fraction of Coxiella burnetii. Antiviral Res. 27(4):1995;389-404